MARKET

ONCS

ONCS

Oncosec Med Inc
NASDAQ
1.700
+0.080
+4.94%
After Hours: 1.650 -0.05 -2.94% 17:38 02/03 EST
OPEN
1.730
PREV CLOSE
1.620
HIGH
1.750
LOW
1.640
VOLUME
111.38K
TURNOVER
0
52 WEEK HIGH
31.90
52 WEEK LOW
1.500
MARKET CAP
5.05M
P/E (TTM)
-0.0938
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 2d ago
Tenax, Innovative top healthcare gainers; OncoSec, Vera among losers
Seeking Alpha · 2d ago
PLTR Stock Alert: Palantir Announces $50 Million Expansion Agreement
Investor Place · 2d ago
Genius Group (GNS) Stock Skyrockets 39% on NFT Plans
Investor Place · 2d ago
Why Is OncoSec Medical (ONCS) Stock Down 25% Today?
Investor Place · 2d ago
Canada Goose Holdings, Hanesbrands among premarket losers' pack
Seeking Alpha · 2d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 2d ago
BRIEF-Oncosec Medical Files For Offering Of 6.2 Million Shares Of Common Stock
Reuters · 3d ago
More
About ONCS
OncoSec Medical Incorporated is a late-stage immuno-oncology company. The Company is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its technology platform, ImmunoPulse, is a drug-device therapeutic modality comprised of intertumoral EP delivery devices, such as the OncoSec Medical System (OMS) EP device. The OMS EP device is designed to deliver plasmid DNA-encoded drugs directly into a solid tumor and promote an immunological response against cancer. The OMS EP device adapts to treat different tumor types and consists of an electrical pulse generator, a reusable handle and disposable applicators. Its product candidate, TAVO is a drug-device combination. The drug consists of a plasmid construct called tavokinogene telseplasmid (TAVO) with plasmid DNA-encoded, IL-12, and is delivered into a tumor using its electroporation device.

Webull offers kinds of OncoSec Medical Inc stock information, including NASDAQ:ONCS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONCS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ONCS stock methods without spending real money on the virtual paper trading platform.